KR20260011772A - 히노키티올 유사체, 이의 제조 방법 및 약제학적 조성물 - Google Patents
히노키티올 유사체, 이의 제조 방법 및 약제학적 조성물Info
- Publication number
- KR20260011772A KR20260011772A KR1020257043492A KR20257043492A KR20260011772A KR 20260011772 A KR20260011772 A KR 20260011772A KR 1020257043492 A KR1020257043492 A KR 1020257043492A KR 20257043492 A KR20257043492 A KR 20257043492A KR 20260011772 A KR20260011772 A KR 20260011772A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- salt
- structural formula
- following structural
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/44—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/717—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a seven- to twelve-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
- C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
- C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/16—Unsaturated compounds
- C07C61/22—Unsaturated compounds having a carboxyl group bound to a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862657127P | 2018-04-13 | 2018-04-13 | |
| US62/657,127 | 2018-04-13 | ||
| PCT/US2019/027314 WO2019200314A2 (en) | 2018-04-13 | 2019-04-12 | Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof |
| KR1020207032644A KR102907811B1 (ko) | 2018-04-13 | 2019-04-12 | 히노키티올 유사체, 이의 제조 방법 및 약제학적 조성물 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020207032644A Division KR102907811B1 (ko) | 2018-04-13 | 2019-04-12 | 히노키티올 유사체, 이의 제조 방법 및 약제학적 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20260011772A true KR20260011772A (ko) | 2026-01-23 |
Family
ID=68163807
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020257043492A Pending KR20260011772A (ko) | 2018-04-13 | 2019-04-12 | 히노키티올 유사체, 이의 제조 방법 및 약제학적 조성물 |
| KR1020207032644A Active KR102907811B1 (ko) | 2018-04-13 | 2019-04-12 | 히노키티올 유사체, 이의 제조 방법 및 약제학적 조성물 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020207032644A Active KR102907811B1 (ko) | 2018-04-13 | 2019-04-12 | 히노키티올 유사체, 이의 제조 방법 및 약제학적 조성물 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12084411B2 (https=) |
| EP (1) | EP3773900A4 (https=) |
| JP (1) | JP7503310B2 (https=) |
| KR (2) | KR20260011772A (https=) |
| CN (1) | CN112672786A (https=) |
| AU (2) | AU2019252933B2 (https=) |
| CA (1) | CA3095945A1 (https=) |
| WO (1) | WO2019200314A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019252933B2 (en) | 2018-04-13 | 2025-09-04 | The Board Of Trustees Of The University Of Illinois | Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof |
| EP4045025A4 (en) * | 2019-10-16 | 2023-11-22 | Kinesid Therapeutics, Inc. | TROPOLONE DERIVATIVES AND THEIR TAUTOMERS FOR IRON REGULATION IN ANIMALS |
| US20230406803A1 (en) * | 2019-10-16 | 2023-12-21 | Kinesid Therapeutics, Inc | Tropolone derivatives and tautomers thereof for iron regulation in animals |
| CN114436909B (zh) * | 2022-01-26 | 2023-05-30 | 河南科技大学 | 一种磺酰基桧木醇类衍生物及其制备方法和应用 |
| CN115093356B (zh) * | 2022-06-21 | 2024-02-23 | 广东医科大学 | 一种铁死亡诱导剂的制备方法与应用 |
| JP2025531628A (ja) * | 2022-09-30 | 2025-09-22 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ | 神経変性疾患の処置方法 |
| CN120282778A (zh) * | 2022-09-30 | 2025-07-08 | 伊利诺伊大学评议会 | 氘化扁柏酚衍生物 |
| CN117547525A (zh) * | 2023-12-29 | 2024-02-13 | 中国科学院长春应用化学研究所 | 天然产物小分子桧木醇在制备治疗非酒精性脂肪性肝炎药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4066784A (en) | 1976-06-17 | 1978-01-03 | Ayerst, Mckenna And Harrison Ltd. | Tropone derivatives |
| US4183955A (en) | 1976-06-17 | 1980-01-15 | Ayerst. McKenna & Harrison Limited | Troponyl-oxamic acid derivatives for treating allergic conditions |
| JP2552870B2 (ja) * | 1986-08-21 | 1996-11-13 | 塩野義製薬株式会社 | 抗マイコプラズマ剤および抗マイコプラズマ活性を有する化合物 |
| JP2622836B2 (ja) * | 1987-02-04 | 1997-06-25 | 富士写真フイルム株式会社 | メチン色素 |
| JPH02237964A (ja) | 1989-03-13 | 1990-09-20 | Nippon Shokubai Kagaku Kogyo Co Ltd | トロポロン誘導体 |
| AU2001258829A1 (en) * | 2000-05-25 | 2001-12-03 | Nippon Shinyaku Co. Ltd. | Tropolone derivatives and pharmaceutical compositions |
| CN1247511C (zh) * | 2000-12-26 | 2006-03-29 | 财团法人乙卯研究所 | 环庚三烯酚酮衍生物 |
| JP2004238291A (ja) * | 2003-02-03 | 2004-08-26 | Osaka Organic Chem Ind Ltd | 白血病細胞増殖阻害剤 |
| US20100152301A1 (en) | 2005-12-01 | 2010-06-17 | Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services | Treatment of Viral Infections |
| JP2008158060A (ja) | 2006-12-21 | 2008-07-10 | Kyocera Mita Corp | 電子写真感光体 |
| JP5948139B2 (ja) * | 2012-05-11 | 2016-07-06 | ヒノキ新薬株式会社 | サーチュイン1(sirt1)遺伝子活性化剤 |
| JP2015526396A (ja) * | 2012-06-22 | 2015-09-10 | ユニバーシティ オブ コネチカット | 置換トロポロン誘導体およびその使用方法 |
| WO2016112381A1 (en) * | 2015-01-09 | 2016-07-14 | The Board Of Trustees Of The University Of Illinois | Restoring physiology in iron-deficient organisms using small molecules |
| WO2017156194A1 (en) | 2016-03-08 | 2017-09-14 | The Regents Of The University Of California | Compositions and methods for inhibiting influenza rna polymerase pa endonuclease |
| US10980754B2 (en) * | 2016-04-19 | 2021-04-20 | Saint Louis University | Anti-fungal compounds |
| AU2019252933B2 (en) | 2018-04-13 | 2025-09-04 | The Board Of Trustees Of The University Of Illinois | Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof |
-
2019
- 2019-04-12 AU AU2019252933A patent/AU2019252933B2/en active Active
- 2019-04-12 WO PCT/US2019/027314 patent/WO2019200314A2/en not_active Ceased
- 2019-04-12 EP EP19784841.9A patent/EP3773900A4/en active Pending
- 2019-04-12 KR KR1020257043492A patent/KR20260011772A/ko active Pending
- 2019-04-12 CN CN201980039697.4A patent/CN112672786A/zh active Pending
- 2019-04-12 JP JP2020554896A patent/JP7503310B2/ja active Active
- 2019-04-12 US US17/046,608 patent/US12084411B2/en active Active
- 2019-04-12 KR KR1020207032644A patent/KR102907811B1/ko active Active
- 2019-04-12 CA CA3095945A patent/CA3095945A1/en active Pending
-
2025
- 2025-08-20 AU AU2025220735A patent/AU2025220735A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021521116A (ja) | 2021-08-26 |
| AU2019252933B2 (en) | 2025-09-04 |
| JP7503310B2 (ja) | 2024-06-20 |
| KR20210020876A (ko) | 2021-02-24 |
| EP3773900A2 (en) | 2021-02-17 |
| US20210163393A1 (en) | 2021-06-03 |
| CA3095945A1 (en) | 2019-10-17 |
| WO2019200314A2 (en) | 2019-10-17 |
| WO2019200314A3 (en) | 2019-11-21 |
| AU2025220735A1 (en) | 2025-09-11 |
| CN112672786A (zh) | 2021-04-16 |
| US12084411B2 (en) | 2024-09-10 |
| EP3773900A4 (en) | 2022-03-30 |
| KR102907811B1 (ko) | 2026-01-02 |
| AU2019252933A1 (en) | 2020-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102907811B1 (ko) | 히노키티올 유사체, 이의 제조 방법 및 약제학적 조성물 | |
| Feng et al. | New deferric amine compounds efficiently chelate excess iron to treat iron overload disorders and to prevent ferroptosis | |
| JP7065115B2 (ja) | フェロポーチン阻害剤塩 | |
| KR102017324B1 (ko) | 신규한 asm 활성 직접 억제 화합물 2-아미노-2-(1,2,3-트리아졸-4-일)프로판-1,3-디올 유도체 및 이의 용도 | |
| CN101468970B (zh) | 一种硝酮类化合物及其制备方法和在制药中的应用 | |
| WO2020028723A1 (en) | Rbp4 antagonists for treatment and prevention of non-alcoholic fatty liver disease and gout | |
| US9072729B2 (en) | Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds | |
| Salehi et al. | Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator | |
| RS55714B1 (sr) | Fosfaplatini i njihova primena za lečenje kancera | |
| KR20190132622A (ko) | 하이드록시벤조산 유도체, 및 그 제조방법 및 용도 | |
| EP2678339B1 (en) | Methods and compositions for treating beta-thalassemia and sickle cell disease | |
| KR102086022B1 (ko) | 칼망가포디피르, 신규 화학 물질 및 기타 혼합 금속 착물, 제조방법, 조성물 및 치료방법 | |
| AU2016220153A9 (en) | Therapeutic compounds | |
| Pathan et al. | Association of late transition metal complexes with ethyl 2-(2-(4-chlorophenylcarbamothioyl) hydrazono) propanoate: Design, synthesis and in vitro anticancer studies | |
| KR102329486B1 (ko) | 할로겐화 화합물 및 이의 축상 키랄성 이성질체 | |
| Zioła et al. | The multifaceted mechanism of action of quinoline thiosemicarbazone based on disruption of iron homeostasis and selective IGF1R inhibition leading to oxidative stress induction | |
| Yu et al. | Rational design of copper ionophores for efficient induction of cuproptosis via simple n-alkyl modification | |
| EP3188726B1 (en) | Pharmaceutical compounds | |
| Rouge et al. | Antiproliferative effect on HepaRG cell cultures of new calix [4] arenes | |
| EP4166137B1 (en) | Therapeutic agent for fatty liver disease | |
| CN106038551A (zh) | Schiglautone A衍生物的组合物用于制备抗红细胞低下性贫血药物 | |
| AU2024325598A1 (en) | Pyridazinone compound and use thereof | |
| EP4594288A2 (en) | Method of treating neurodegenerative diseases | |
| HK40089150B (en) | Therapeutic agent for fatty liver disease | |
| JP2007191451A (ja) | プロリル水酸化酵素阻害剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A16 | Divisional, continuation or continuation in part application filed |
Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A16-DIV-PA0104 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PA0104 | Divisional application for international application |
St.27 status event code: A-0-1-A10-A16-div-PA0104 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| Q12 | Application published |
Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-NAP-PG1501 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |